Biostage (BSTG) News Today $4.45 0.00 (0.00%) As of 07/24/2023 Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Jefferies maintains Buy on Biostage shares with raised target amid bullish growth outlookJanuary 22, 2025 | msn.comHarvard Apparatus Regenerative Technology Inc (HRGN)January 5, 2024 | investing.comHRGN Harvard Apparatus Regenerative Technology Inc.August 22, 2023 | seekingalpha.comBiostage, Inc. Changes Name to Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN)July 20, 2023 | finance.yahoo.comBiostage Activated Mayo Clinic as The First Site for Clinical Trial in Severe Esophageal DiseaseJuly 18, 2023 | finance.yahoo.comBiostage CEO Awarded $1.07M Worth of Stock OptionsJuly 11, 2023 | benzinga.comBiostage to Host Investor CallJune 13, 2023 | finance.yahoo.comBiostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal DiseaseMay 31, 2023 | finance.yahoo.comBiostage Stock (OTC:BSTG), Insider Trading ActivityMay 16, 2023 | benzinga.comBiostage, Inc. (BSTG) stock historical prices & data – Yahoo FinanceApril 24, 2023 | sg.finance.yahoo.comBiostage, Inc. (BSTG) Stock Historical Prices & Data - Yahoo FinanceApril 23, 2023 | ca.finance.yahoo.comBiostage Appoints Ron Packard to Board of DirectorsApril 10, 2023 | finance.yahoo.comBiostage Announces $6 Million Financing to Advance Clinical TrialApril 6, 2023 | finance.yahoo.comBiostage Announces Chairman and CEO TransitionMarch 2, 2023 | finance.yahoo.comRegenerative medicine developer Biostage cancels Nasdaq uplisting, public offeringFebruary 3, 2023 | msn.comBiostage Amends CEO Employment AgreementJanuary 12, 2023 | finance.yahoo.comBiostage, Inc. (OTC:BSTG) Q3 2022 Earnings Call TranscriptDecember 28, 2022 | finance.yahoo.comBiostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including CancerDecember 28, 2022 | prnewswire.comNew Publication Demonstrates Rapid Esophageal Regeneration using the Biostage Esophageal ImplantDecember 23, 2022 | finance.yahoo.comBiostage, Inc. (BSTG) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | seekingalpha.comBiostage Reports Corporate Highlights and Third Quarter Financial ResultsNovember 15, 2022 | finance.yahoo.comBiostage Schedules Conference Call and Webcast for Q3 2022 ResultsNovember 10, 2022 | finance.yahoo.comRegenerative therapy developer Biostage files for Nasdaq uplisting, $6M offeringOctober 29, 2022 | seekingalpha.comBiostage Receives U.S. Patent for Cellularized Patch-Based Scaffolds for Organ RepairOctober 25, 2022 | finance.yahoo.comBiostage Announces Appointment of New Chief Financial OfficerAugust 8, 2022 | finance.yahoo.comBiostage Reports Corporate Highlights and Second Quarter Financial ResultsAugust 4, 2022 | finance.yahoo.comBiostage Schedules Conference Call and Webcast for Q2 2022 ResultsAugust 4, 2022 | finance.yahoo.comBiostage Begins U.S. Uplisting IPO RolloutJune 24, 2022 | seekingalpha.comBiostage Announces Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Journal of BiomechanicsJune 15, 2022 | finance.yahoo.comBiostage, Inc. (BSTG) Interim CEO David Green on Q1 2022 Results - Earnings Call TranscriptMay 17, 2022 | seekingalpha.comBiostage Reports Q1 2022 Financial Results and Corporate HighlightsMay 16, 2022 | finance.yahoo.comBiostage Announces $5.1 Million Financing to Advance Clinical Trial | MorningstarMay 15, 2022 | morningstar.comCell-therapy biotechnology company Biostage raises ~$5.1M to advance clinical trialMay 13, 2022 | seekingalpha.comBiostage Schedules Conference Call and Webcast for Q1 2022 ResultsMay 10, 2022 | finance.yahoo.comBiostage Further Strengthens IP Portfolio with Additional Patent for Regeneration and Repair of the BronchusApril 11, 2022 | finance.yahoo.comWe Could Use Ultrasound to Command Bacteria to Nuke TumorsApril 1, 2022 | yahoo.comYouTube may be getting a dedicated podcasts homepageApril 1, 2022 | yahoo.comBiostage Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsApril 1, 2022 | finance.yahoo.comBiostage Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsApril 1, 2022 | finance.yahoo.comBiostage Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2021 Financial ResultsMarch 30, 2022 | finance.yahoo.comBiostage rebounds after announcing court ruling against insurance carrierJanuary 25, 2022 | seekingalpha.comBiostage Announces Court's Preliminary Injunction Order Requiring its Insurance Carrier to Continue Paying for DefenseJanuary 25, 2022 | finance.yahoo.comBiostage Announces "Meet the Founder, New Chairman and Interim CEO" WebinarJanuary 25, 2022 | finance.yahoo.comNew Paper Shows Biostage's Esophageal Implant Regenerates the Esophagus in PigletsJanuary 10, 2022 | finance.yahoo.comBiostage Hires David Green as Chief Executive OfficerNovember 30, 2021 | finance.yahoo.comOconto man gets over three years in prison for 5th, 6th drunken-driving convictionsNovember 17, 2021 | yahoo.comMark Cuban's Fireside app attracts NFL stars and others as backersNovember 17, 2021 | yahoo.comBiostage Reports Q3 2021 Financial ResultsNovember 15, 2021 | finance.yahoo.comBiostage™ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Clinical TransitionSeptember 8, 2021 | finance.yahoo.comBiostage Reports Q2 2021 Financial ResultsAugust 13, 2021 | finance.yahoo.com Get Biostage News Delivered to You Automatically Sign up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter. Email Address BSTG Media Mentions By Week BSTG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BSTG News Sentiment▼0.000.85▲Average Medical News Sentiment BSTG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BSTG Articles This Week▼00▲BSTG Articles Average Week Get Biostage News Delivered to You Automatically Sign up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SANUWAVE Health News Today Nevro News Today Pro-Dex News Today Pulmonx News Today Nyxoah News Today Electromed News Today Inogen News Today Alpha Tau Medical News Today Anteris Technologies Global News Today BrainsWay News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BSTG) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biostage, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biostage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.